22 results
8-K
EX-3.2
CELL
Bruker Cellular Analysis, Inc.
2 Oct 23
Completion of Acquisition or Disposition of Assets
8:47am
and vote at such meeting, and the place within the city or other municipality or community at which the list of stockholders may be examined, shall
SC 14D9
CELL
Bruker Cellular Analysis, Inc.
31 Aug 23
Tender offer solicitation
4:47pm
, stating that “proof of value by any techniques or methods which are generally considered acceptable in the financial community and otherwise admissible
SC TO-T
EX-99
CELL
Bruker Cellular Analysis, Inc.
31 Aug 23
Third party tender offer statement
4:11pm
, as amended.
A middleman known in the investment community as a nominee or custodian.
A futures commission merchant registered with the Commodity
425
ISO
IsoPlexis Corp
22 Dec 22
Business combination disclosure
6:19pm
in the proteomic space and a powerful contributor to the broader scientific community, we're known for our leading IsoCode cellular behavior multiplexing
425
EX-10.2
3v0lnvv
21 Dec 22
Business combination disclosure
5:28pm
8-K
EX-10.2
q6875qfnfkl3 t8d
21 Dec 22
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
5:27pm
DEF 14A
e70147umr1n7nn
1 Apr 21
Definitive proxy
12:00am
424B4
qfxlxawtdv41k0p1 jfz
19 Nov 20
Prospectus supplement with pricing info
4:09pm
DRS
z63wtw89
6 Nov 20
Draft registration statement
12:00am
424B4
c16fy9dehs4 wh2875h8
17 Jul 20
Prospectus supplement with pricing info
4:33pm
S-1
EX-10.1
3xza ms5vucy92bd
26 Jun 20
IPO registration
4:31pm
S-1
rvtoan63u6xc
26 Jun 20
IPO registration
4:31pm
DRS/A
EX-10.1
ij58pie8
12 Jun 20
Draft registration statement (amended)
12:00am